Rani Therapeutics Holdings Inc (NAS:RANI)
$ 2.51 0.03 (1.21%) Market Cap: 81.55 Mil Enterprise Value: 84.60 Mil PE Ratio: 0 PB Ratio: 22.82 GF Score: 32/100

Rani Therapeutics Holdings Inc at Needham Healthcare Conference (Virtual) Transcript

Apr 14, 2022 / 07:45PM GMT
Release Date Price: $13 (-3.49%)
Serge D. Belanger
Needham & Company, LLC, Research Division - Senior Analyst

Good afternoon. Welcome to Needham's Annual Healthcare Conference. I'm Serge Belanger, one of the health care analysts at Needham. And we're happy to have this afternoon for our next session, Rani Therapeutics. We have a lot of team members here. I think the CEO, Talat Imran, will give us -- will introduce his colleagues as well as give us an overview of the company. We'll then proceed to some Q&A. And for those listening online, you do have the option to submit questions through the portal. We'll be checking that as we proceed with the Q&A portion. So I'll hand it over to Talat to -- with the overview.

Talat Imran;Serge D. Belanger
Rani Therapeutics Holdings, Inc. - CEO & Director;Needham & Company, LLC, Research

Great. Thank you so much, Serge, and thank you to Needham for allowing us the opportunity to present at the conference. I'm going to pull up the deck now, and hopefully, you're able to see this. Does that look good?

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot